Nordisk tumbles on lowered outlook

Shares in Novo Nordisk (NYSE:NVO) fell -9% this morning after the pharmaceutical company missed expectations on Wall Street with its 4th quarter results and lowered its outlook for 2017.

The Danish company posted profits of 8.7 billion Danish kroner, or $1.26 billion USD, on sales of 29.57 billion kroner for the 3 months ended Dec. 31, for bottom-line growth of 5% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Nordisk tumbles on lowered outlook appeared first on MassDevice.

from MassDevice http://ift.tt/2k4oJVg